Key result
A 10-day yoga-based lifestyle intervention significantly reduced mean cortisol (149.95 to 129.07 ng/mL, p=0.001) and TNF-α (2.85 to 1.95 pg/mL, p=0.002) from baseline in patients with chronic diseases.
Why the study?
Does a 10-day yoga-based lifestyle intervention reduce biomarkers of stress and inflammation in patients with chronic inflammatory diseases and overweight/obesity?
Observational (n=86)
No
Does a 10-day yoga-based lifestyle intervention reduce biomarkers of stress and inflammation in patients with chronic inflammatory diseases and overweight/obesity?
A brief 10-day yoga-based lifestyle intervention may significantly improve biomarkers of stress and inflammation in patients with chronic inflammatory diseases and obesity.
May support yoga for stress/inflammation biomarkers in chronic disease; hypothesis-generating and requires RCTs before practice change.
OBJECTIVES: Previously it was shown that a brief yoga-based lifestyle intervention was efficacious in reducing oxidative stress and risk of chronic diseases even in a short duration. The objective of this study was to assess the efficacy of this intervention in reducing stress and inflammation in patients with chronic inflammatory diseases. DESIGN: This study reports preliminary results from a nonrandomized prospective ongoing study with pre-post design. SETTING/LOCATION: The study was conducted at the Integral Health Clinic, an outpatient facility conducting these yoga-based lifestyle intervention programs for prevention and management of chronic diseases. SUBJECTS: Patients with chronic inflammatory diseases and overweight/obese subjects were included while physically challenged, and those on other interventions were excluded from the study. INTERVENTION: A pretested intervention program included asanas (postures), pranayama (breathing exercises), stress management, group discussions, lectures, and individualized advice. OUTCOME MEASURES: There was a reduction in stress (plasma cortisol and β-endorphin) and inflammation (interleukin [IL]-6 and tumor necrosis factor [TNF]-α) at day 0 versus day 10. RESULTS: Eighty-six (86) patients (44 female, 42 male, 40.07 ± 13.91 years) attended this program. Overall, the mean level of cortisol decreased from baseline to day 10 (149.95 ± 46.07, 129.07 ± 33.30 ng/mL; p=0.001) while β-endorphins increased from baseline to day 10 (3.53 ± 0.88, 4.06 ± 0.79 ng/mL; p=0.024). Also, there was reduction from baseline to day 10 in mean levels of IL-6 (2.16 ± 0.42, 1.94 ± 0.10 pg/mL, p=0.036) and TNF-α (2.85 ± 0.59, 1.95 ± 0.32 pg/mL, p=0.002). CONCLUSIONS: This brief yoga-based lifestyle intervention reduced the markers of stress and inflammation as early as 10 days in patients with chronic diseases; however, complete results of this study will confirm whether this program has utility as complementary and alternative therapy.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2012) conducted an observational in chronic inflammatory diseases and overweight/obese (n=86). yoga-based lifestyle intervention vs. baseline was evaluated on stress (plasma cortisol and β-endorphin) and inflammation (interleukin [IL]-6 and tumor necrosis factor [TNF]-α). A 10-day yoga-based lifestyle intervention significantly reduced mean cortisol (149.95 to 129.07 ng/mL, p=0.001) and TNF-α (2.85 to 1.95 pg/mL, p=0.002) from baseline in patients with chronic diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: